“Loss of LBP in Rats with NAFLD Triggers Lipid Metabolic Disorder and Aggravates Disease: H3K27 Acetylation-Mediated C/EBPβ-SCD Activation as Potential Targets”

https://pubmed.ncbi.nlm.nih.gov/38114435

The study finds that the loss of LBP in rats with non-alcoholic fatty liver disease (NAFLD) triggers lipid metabolic disorder through H3K27 acetylation-mediated C/EBPβ-SCD activation, aggravating the disease and highlighting potential therapeutic targets.